Unified approaches to assessing treatment effect of traditional Chinese medicine based on health profiles.
Publication
, Journal Article
Cheng, B; Zhang, B; Chow, S-C
Published in: J Biopharm Stat
May 3, 2020
Two dissimilarity indices are introduced to measure the disharmony of a human body system by mimicking the population bioequivalence and the individual bioequivalence concepts. Hypotheses for the treatment effect of a traditional Chinese medicine are formulated based on the two indices and then tested under the proposed designs by reverting an approximate confidence upper bound. The proposed methods can also be used when a drug product has multiple components or a trial has multiple endpoints.
Duke Scholars
Published In
J Biopharm Stat
DOI
EISSN
1520-5711
Publication Date
May 3, 2020
Volume
30
Issue
3
Start / End Page
564 / 573
Location
England
Related Subject Headings
- Treatment Outcome
- Therapeutic Equivalency
- Statistics & Probability
- Principal Component Analysis
- Medicine, Chinese Traditional
- Humans
- Biosimilar Pharmaceuticals
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cheng, B., Zhang, B., & Chow, S.-C. (2020). Unified approaches to assessing treatment effect of traditional Chinese medicine based on health profiles. J Biopharm Stat, 30(3), 564–573. https://doi.org/10.1080/10543406.2020.1726368
Cheng, Bin, Bingzhi Zhang, and Shein-Chung Chow. “Unified approaches to assessing treatment effect of traditional Chinese medicine based on health profiles.” J Biopharm Stat 30, no. 3 (May 3, 2020): 564–73. https://doi.org/10.1080/10543406.2020.1726368.
Cheng B, Zhang B, Chow S-C. Unified approaches to assessing treatment effect of traditional Chinese medicine based on health profiles. J Biopharm Stat. 2020 May 3;30(3):564–73.
Cheng, Bin, et al. “Unified approaches to assessing treatment effect of traditional Chinese medicine based on health profiles.” J Biopharm Stat, vol. 30, no. 3, May 2020, pp. 564–73. Pubmed, doi:10.1080/10543406.2020.1726368.
Cheng B, Zhang B, Chow S-C. Unified approaches to assessing treatment effect of traditional Chinese medicine based on health profiles. J Biopharm Stat. 2020 May 3;30(3):564–573.
Published In
J Biopharm Stat
DOI
EISSN
1520-5711
Publication Date
May 3, 2020
Volume
30
Issue
3
Start / End Page
564 / 573
Location
England
Related Subject Headings
- Treatment Outcome
- Therapeutic Equivalency
- Statistics & Probability
- Principal Component Analysis
- Medicine, Chinese Traditional
- Humans
- Biosimilar Pharmaceuticals
- 1115 Pharmacology and Pharmaceutical Sciences